Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Japanese researchers present novel GPR119 receptor agonists

Sep. 20, 2012

New ghrelin receptor antagonists disclosed by Helsinn Healthcare

Sep. 19, 2012

Japanese scientists synthesize novel agents for thromboembolic disorders

Sep. 19, 2012

Eternity Biosciences prepares new protein kinase inhibitors

Sep. 19, 2012

Suven Life Sciences discloses new H3 receptor ligands

Sep. 19, 2012

Astellas Pharma presents novel antifungal agents

Sep. 19, 2012

Canadian and U.S. group patents new antibacterial agents

Sep. 19, 2012

Novel nicotinic acetylcholine alpha7 receptor modulators disclosed by Lupin

Sep. 18, 2012

Janssen Pharmaceutica patents new alpha7 receptor modulators

Sep. 18, 2012

New GlyT-1 inhibitors disclosed by Taisho Pharmaceutical

Sep. 18, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026